HEALWELL Provides Corporate Update Including Improved Performance in AI Business, Acquisition of Remaining Interest in Pentavere and Deeper Integration within the AI Business Segment | HWAIF Stock New

1 day ago

HEALWELL AI (OTCQX: HWAIF) reports 200% year-over-year growth in AI segment revenue for H1 2025, surpassing $5 million.
Acquisition of the remaining 49% stake in Pentavere Research Group for approximately $14 million.
Expected positive Adjusted EBITDA for the AI business segment in H1 2025, driven by 100% organic revenue growth in Pentavere and Khure Health.

HEALWELL AI Inc. (OTCQX: HWAIF), a leading healthcare artificial intelligence company, has announced impressive growth figures for its core AI business division. Preliminary revenues for the segment are expected to exceed $5 million for the first half of 2025, marking a significant 200% increase compared to the same timeframe last year. This robust performance is anticipated to result in a positive Adjusted EBITDA for the AI segment in H1 2025.

In a strategic move to consolidate its technological prowess, HEALWELL has successfully acquired the remaining 49% stake in Pentavere Research Group. The acquisition, valued at approximately $14 million, was completed through the issuance of 10.16 million Subordinate Voting Shares. With full ownership, HEALWELL aims to enhance the integration of Pentavere’s DARWEN™ platform, a leading AI-driven patient identification solution, into its AI offerings.

Under the new leadership of CEO James Lee, effective July 1, 2025, HEALWELL's AI division, including Pentavere, Khure Health, and Mutuo Health Solutions, has demonstrated substantial growth. Notably, both Pentavere and Khure Health achieved over 100% organic revenue growth in the first half of 2025. This reinforces the company's strategy to leverage its AI and data science products within its software platforms, thereby strengthening its market presence in the healthcare sector.

Chairman Hamed Shahbazi expressed enthusiasm about the DARWEN™ platform's unique capabilities, emphasizing its validation across over 40 clinical publications. The platform is positioned as a leader in providing AI insights for preventative healthcare, with significant interest emerging from major healthcare systems globally.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.